Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 1
1995 2
1996 2
1997 1
1999 2
2000 2
2001 2
2002 2
2003 3
2004 1
2005 2
2006 4
2007 1
2008 5
2009 3
2010 1
2011 4
2012 6
2013 4
2014 6
2015 7
2016 9
2017 6
2018 16
2019 11
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32732372

101 results
Results by year
Filters applied: . Clear all
Page 1
A Patient Perspective on Genetic Testing for ADPKD: The Lack of Complete Genetic Information, Especially Early in the Course of the Disease, Is Harming Adult Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients.
Odland D. Odland D. Clin J Am Soc Nephrol. 2020 Jul 30:CJN.14051119. doi: 10.2215/CJN.14051119. Online ahead of print. Clin J Am Soc Nephrol. 2020. PMID: 32732372 No abstract available.
Polycystic Kidney Disease, Autosomal Dominant.
Harris PC, Torres VE. Harris PC, et al. 2002 Jan 10 [updated 2018 Jul 19]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. GeneReviews®. 1993–2020. PMID: 20301424 Free Books & Documents. Review.
ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
Reule S, Sexton DJ, Solid CA, Chen SC, Collins AJ, Foley RN. Reule S, et al. Am J Kidney Dis. 2014 Oct;64(4):592-9. doi: 10.1053/j.ajkd.2014.05.020. Epub 2014 Aug 16. Am J Kidney Dis. 2014. PMID: 25134777 Free PMC article.
Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model.
Bennett H, McEwan P, Hamilton K, O'Reilly K. Bennett H, et al. BMC Nephrol. 2019 Apr 23;20(1):136. doi: 10.1186/s12882-019-1290-5. BMC Nephrol. 2019. PMID: 31014270 Free PMC article. Clinical Trial.
Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
Blanchette CM, Craver C, Belk KW, Lubeck DP, Rossetti S, Gutierrez B. Blanchette CM, et al. J Med Econ. 2015 Apr;18(4):303-11. doi: 10.3111/13696998.2014.985381. Epub 2015 Jan 20. J Med Econ. 2015. PMID: 25372357
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model.
McEwan P, Bennett Wilton H, Ong ACM, Ørskov B, Sandford R, Scolari F, Cabrera MV, Walz G, O'Reilly K, Robinson P. McEwan P, et al. BMC Nephrol. 2018 Feb 13;19(1):37. doi: 10.1186/s12882-017-0804-2. BMC Nephrol. 2018. PMID: 29439650 Free PMC article. Clinical Trial.
Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.
Reiterová J, Štekrová J, Merta M, Kotlas J, Elišáková V, Lněnička P, Korabečná M, Kohoutová M, Tesař V. Reiterová J, et al. BMC Nephrol. 2013 Mar 15;14:59. doi: 10.1186/1471-2369-14-59. BMC Nephrol. 2013. PMID: 23496908 Free PMC article.
101 results
Jump to page